Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cy3 maleimide non sulfonated 25mg'

Search results for: 'cy3 maleimide non sulfonated 25mg'

Items 31-40 of 139

Page
per page
  1. Dovitinib Dilactic acid
    A8418 Dovitinib Dilactic acid
    Summary: FLT3 inhibitor
      ≥57.3 mg/mL
  2. LY2874455
    A3576 LY2874455
    Summary: FGF/FGFR Inhibitor
      ≥44.4 mg/mL
  3. GNF 5
    A8604 GNF 5
    Target: Bcr-Abl
    Summary: Bcr-Abl inhibitor
  4. Butein
    A2689 Butein
    Target: Src|STAT|EGFR|Angiotensin-Converting Enzymes (ACEs)|5-Lipoxygenases|PTK|enoyl-acyl-carrier protein reductase
    Summary: Protein kinase inhibitor
      insoluble in H2O; ≥13.6 mg/mL
  5. SU6656
    B5839 SU6656
    Target: Src|Lyn|YES|Fyn
    Summary: Src tyrosine kinases inhibitor
      insoluble in H2O; insoluble in EtOH; ≥18.55 mg/mL
  6. Masitinib (AB1010)
    A2942 Masitinib (AB1010)
    Target: PDGFR|c-Kit|Lyn
    Summary: Tyrosine kinase inhibitor, potent and selective
      ≥24.95 mg/mL
  7. SU11274
    A2678 SU11274
     2 Citation
    Target: MET
    Summary: C-Met inhibitor,potent and selective
      ≥28.4 mg/mL
  8. Ki8751
    A1821 Ki8751
    Target: VEGFR
    Summary: VEGFR-2 inhibitor,potent and selective
      ≥23.45 mg/mL
  9. WZ8040
    A1393 WZ8040
    Target: EGFR
    Summary: EGFR T790M inhibitor,irreversible amd potent
      ≥24.05 mg/mL
  10. GNF-7
    B6033 GNF-7
    Summary: Type II Bcr-Abl inhibitor
      insoluble in EtOH; insoluble in H2O; ≥5.48 mg/mL

Items 31-40 of 139

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 8item
  2. Axl 3item
  3. ALK 8item
  4. Broad Spectrum Protein Kinase Inhibitor 2item
  5. c-Kit 3item
  6. c-MET 13item
  7. CSF-1R 1 item
  8. EGFR 26item
  9. FAK 4item
  10. FGFR 7item
  11. FLT3 7item
  12. HER2 6item
  13. IGF1R 5item
  14. Insulin Receptor 1 item
  15. LRRK2 4item
  16. PDGFR 9item
  17. PTKs/RTKs 1 item
  18. Pyk2 2item
  19. ROR 4item
  20. Spleen Tyrosine Kinase (Syk) 6item
  21. Src 9item
  22. Tie-2 2item
  23. Trk 3item
  24. VEGFR 26item
Specificity
  1. Selective 55item
Reversibility
  1. Reversible 6item
  2. Irreversible 6item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Raf 1 item
  3. CSF-1R 3item
  4. MER 1 item
  5. FLT3 6item
  6. VEGFR 18item
  7. PDGFR 13item
  8. c-Kit 4item
  9. RET 1 item
  10. Bcr-Abl 6item
  11. FGFR 10item
  12. MET 4item
  13. Src 8item
  14. Trk Receptors 3item
  15. STAT 1 item
  16. EGFR 11item
  17. FAK 3item
  18. BMP and Other Activin Receptors 1 item
  19. JAK 2item
  20. Syk 4item
  21. ErbB 2item
  22. c-MET 5item
  23. PKC 1 item
  24. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  25. Lyn 2item
  26. Pyk2 3item
  27. LRRK2 3item
  28. Insulin and Insulin-like Receptors 1 item
  29. ALK 3item
  30. ROS1 2item
  31. Angiotensin-Converting Enzymes (ACEs) 1 item
  32. Tie-2 2item
  33. c-Fyn 1 item
  34. 5-Lipoxygenases 1 item
  35. Insulin Receptors 1 item
  36. IRG-1R 1 item
  37. ZAP-70 1 item
  38. TAM kinase 1 item
  39. insulin 1 item
  40. PTK 1 item
  41. Flk1 1 item
  42. YES 1 item
  43. Fyn 1 item
  44. enoyl-acyl-carrier protein reductase 1 item
  45. tropomyosin receptor kinase 1 item
  46. Insulin Receptor 1 item
Reported Experiments
  1. Animal Experiments 66item
  2. Cell Experiments 44item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 2item
  3. Adrenocortical Carcinoma 1 item
  4. Advanced Renal Cell Carcinoma 1 item
  5. Bladder Cancer 1 item
  6. Breast Cancer 11item
  7. Cancer 49item
  8. Chronic Lymphocytic Leukemia 1 item
  9. Clear Cell Renal Cell Carcinoma 1 item
  10. Colon Cancer 2item
  11. Colon Carcinoma 1 item
  12. Colorectal Cancer 5item
  13. Glioblastoma 1 item
  14. Glioma 3item
  15. Hepatocellular Carcinoma 3item
  16. Leukemia 1 item
  17. Lung Cancer 4item
  18. Lung Carcinoma 3item
  19. Lymphoma 1 item
  20. Multiple Myeloma 3item
  21. Neuroblastoma 1 item
  22. Non-small Cell Lung Cancer 2item
  23. Ovarian Cancer 4item
  24. Pancreatic Cancer 7item
  25. Prostate Cancer 4item
  26. Pulmonary Arterial Hypertension 1 item
  27. Renal Cancer 1 item
  28. Renal Cell Carcinoma 2item
  29. Thyroid Cancer 1 item